Researchers have developed AI tools capable of designing novel proteins and even entire synthetic genomes from scratch, a breakthrough that could revolutionize biotechnology but also raises profound ethical questions about altering life.

MIT Professor Jim Collins leads groundbreaking research using generative AI to design programmable antibacterials targeting drug-resistant pathogens.